Mesothelioma Survivor Rising with Immunotherapy – Asbestos.com (blog)
Asbestos.com (blog) |
Mesothelioma Survivor Rising with Immunotherapy
Asbestos.com (blog) Hartline, who was first diagnosed in July 2016, has been receiving the experimental immunotherapy drug nivolumab – also known by brand name Opdivo – for the last seven months. He returns to Balaraman's nearby office every two weeks for an hour of IV … |
